Breast Cancer Research

official impact factor 5.79

Highly Access

High-throughput genomic technology in research and clinical management of breast cancer. Plasma-based proteomics in early detection and therapy

Michael A Davis and Samir Hanash*

Breast Cancer Research 2006, 8:217 doi:10.1186/bcr1619

Accesses  

  • Last 30 days: 52 accesses
  • Last 365 days: 554 accesses
  • All time: 5352 accesses

Cited by

BioMed Central: 1 citation

Review   Open Access

Applying mass spectrometry based proteomic technology to advance the understanding of multiple myeloma

Johann Micallef, Moyez Dharsee, Jian Chen, Suzanne Ackloo, Ken Evans, Luqui Qiu, Hong Chang Journal of Hematology & Oncology 2010, 3:13 (7 April 2010)